Table 3.
Lipid profile in rats pretreated with AHALE and AHALE-ZnONPs followed by ISO exposure.
| Treatment | TG (mg/dl) | TC (mg/dl) | HDL (mg/dl) | LDL (mg/dl) |
|---|---|---|---|---|
| Control | 63.2 ± 3.1 d | 78.5 ± 3.4c | 31.2 ± 3.4 a | 43.1 ± 2.1 e |
| Isoproterenol | 95.6 ± 5.7 a | 129.6 ± 7.1 a | 22.1 ± 1.8c | 91.4 ± 3.5 a |
| AHALE50 + ISO | 89.2 ± 6.4 a | 118.4 ± 6.6 a | 22.9 ± 2.2c | 87.5 ± 2.7 a |
| AHALE150 + ISO | 81.4 ± 6.8b | 103.1 ± 5.3b | 23.7 ± 1.3b,c | 78.7 ± 2.2b |
| AHALE300 + ISO | 76.8 ± 4.5b,c | 97.5 ± 6.1b,c | 25.4 ± 2.4b | 64.2 ± 1.8c |
| AHALE-ZnONPs 50 + ISO | 83.5 ± 5.1 a,b | 106.2 ± 5.8b | 23.5 ± 3.6b,c | 79.6 ± 3.4b |
| AHALE-ZnONPs 150 + ISO | 74.9 ± 4.9c | 95.1 ± 4.9b,c | 27.2 ± 1.5 a,b | 66.1 ± 2.6c |
| AHALE-ZnONPs 300 + ISO | 66.3 ± 2.5 d | 83.6 ± 3.3c | 29.7 ± 3.1 a | 52.4 ± 1.3 d |
MI: Myocardial infarction; AHALE: A. herba alba leaves extract; ZnONPs: Zinc Oxide nanoparticles; 50, 150, and 300: doses of AHALE or AHALE-ZnONPs; Data are presented as mean ± SEM. a,b,c,d,e Mean values within treatment with different superscript letters were significantly different (p < 0.05).